Published in Mol Cell Biol on January 01, 2000
Sex differences in the expression of hepatic drug metabolizing enzymes. Mol Pharmacol (2009) 2.45
Priming for T helper type 2 differentiation by interleukin 2-mediated induction of interleukin 4 receptor alpha-chain expression. Nat Immunol (2008) 2.31
Critical Role of STAT5 transcription factor tetramerization for cytokine responses and normal immune function. Immunity (2012) 2.16
STAT3- and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes. Proc Natl Acad Sci U S A (2005) 1.80
Epigenetic repression of the Igk locus by STAT5-mediated recruitment of the histone methyltransferase Ezh2. Nat Immunol (2011) 1.59
The next generation of transcription factor binding site prediction. PLoS Comput Biol (2013) 1.55
Jak2-Stat5a/b Signaling Induces Epithelial-to-Mesenchymal Transition and Stem-Like Cell Properties in Prostate Cancer. Am J Pathol (2015) 1.44
Loss of sexually dimorphic liver gene expression upon hepatocyte-specific deletion of Stat5a-Stat5b locus. Endocrinology (2007) 1.39
Prolactin inhibits BCL6 expression in breast cancer through a Stat5a-dependent mechanism. Cancer Res (2010) 1.23
Interleukin-7 receptor signaling network: an integrated systems perspective. Cell Mol Immunol (2008) 1.22
In vivo identification of novel STAT5 target genes. Nucleic Acids Res (2008) 1.19
STAT5 requires the N-domain to maintain hematopoietic stem cell repopulating function and appropriate lymphoid-myeloid lineage output. Exp Hematol (2007) 1.19
STAT5 and Oct-1 form a stable complex that modulates cyclin D1 expression. Mol Cell Biol (2003) 1.12
Dynamic in vivo binding of STAT5 to growth hormone-regulated genes in intact rat liver. Sex-specific binding at low- but not high-affinity STAT5 sites. Mol Endocrinol (2009) 1.09
Sex-specific early growth hormone response genes in rat liver. Mol Endocrinol (2008) 1.08
t(8;21)(q22;q22) Fusion proteins preferentially bind to duplicated AML1/RUNX1 DNA-binding sequences to differentially regulate gene expression. Blood (2008) 1.07
Mapping the growth hormone--Stat5b--IGF-I transcriptional circuit. Trends Endocrinol Metab (2012) 1.07
Stat5 promotes survival of mammary epithelial cells through transcriptional activation of a distinct promoter in Akt1. Mol Cell Biol (2010) 1.05
The different functions of Stat5 and chromatin alteration through Stat5 proteins. Front Biosci (2008) 1.05
Developmental programming mediated by complementary roles of imprinted Grb10 in mother and pup. PLoS Biol (2014) 1.05
Role of the Stat4 N domain in receptor proximal tyrosine phosphorylation. Mol Cell Biol (2000) 1.04
Endogenous retrovirus-K promoter: a landing strip for inflammatory transcription factors? Retrovirology (2013) 1.00
STAT5A-mediated SOCS2 expression regulates Jak2 and STAT3 activity following c-Src inhibition in head and neck squamous carcinoma. Clin Cancer Res (2011) 0.99
Alternative ways of modulating JAK-STAT pathway: Looking beyond phosphorylation. JAKSTAT (2012) 0.99
Variable structure motifs for transcription factor binding sites. BMC Genomics (2010) 0.95
The STAT5b Pathway Defect and Autoimmunity. Front Immunol (2012) 0.94
GM-CSF induces STAT5 binding at epigenetic regulatory sites within the Csf2 promoter of non-obese diabetic (NOD) mouse myeloid cells. J Autoimmun (2008) 0.92
IL-2 regulates expression of C-MAF in human CD4 T cells. J Immunol (2011) 0.90
Transcription factor Stat5a/b as a therapeutic target protein for prostate cancer. Int J Biochem Cell Biol (2009) 0.90
Signalling cross-talk between hepatocyte nuclear factor 4alpha and growth-hormone-activated STAT5b. Biochem J (2006) 0.90
Prolactin regulation of the prostate gland: a female player in a male game. Nat Rev Urol (2011) 0.90
Activating FLT3 mutants show distinct gain-of-function phenotypes in vitro and a characteristic signaling pathway profile associated with prognosis in acute myeloid leukemia. PLoS One (2014) 0.90
Evidence for a role of prolactin in calcium homeostasis: regulation of intestinal transient receptor potential vanilloid type 6, intestinal calcium absorption, and the 25-hydroxyvitamin D(3) 1alpha hydroxylase gene by prolactin. Endocrinology (2010) 0.89
Differentiating the roles of STAT5B and STAT5A in human CD4+ T cells. Clin Immunol (2013) 0.87
Identification of STAT5A and STAT5B target genes in human T cells. PLoS One (2014) 0.85
An autoregulatory enhancer controls mammary-specific STAT5 functions. Nucleic Acids Res (2015) 0.84
Targeted blockage of signal transducer and activator of transcription 5 signaling pathway with decoy oligodeoxynucleotides suppresses leukemic K562 cell growth. DNA Cell Biol (2010) 0.83
Targeting transcription factor Stat5a/b as a therapeutic strategy for prostate cancer. Am J Transl Res (2010) 0.83
Signal transducer and activator of transcription 5 (STAT5) paralog dose governs T cell effector and regulatory functions. Elife (2016) 0.81
Glucose-6-phosphate dehydrogenase and NADPH oxidase 4 control STAT3 activity in melanoma cells through a pathway involving reactive oxygen species, c-SRC and SHP2. Am J Cancer Res (2015) 0.80
STAT5 acetylation: Mechanisms and consequences for immunological control and leukemogenesis. JAKSTAT (2013) 0.80
Signal transducer and activator of transcription STAT5 is recruited to c-Myc super-enhancer. BMC Mol Biol (2016) 0.78
Genome-wide screening in human growth plates during puberty in one patient suggests a role for RUNX2 in epiphyseal maturation. J Endocrinol (2011) 0.77
STAT5-induced lunatic fringe during Th2 development alters delta-like 4-mediated Th2 cytokine production in respiratory syncytial virus-exacerbated airway allergic disease. J Immunol (2013) 0.77
FRA2 is a STAT5 target gene regulated by IL-2 in human CD4 T cells. PLoS One (2014) 0.77
ConBind: motif-aware cross-species alignment for the identification of functional transcription factor binding sites. Nucleic Acids Res (2015) 0.76
Phosphorylated STAT5 directly facilitates parvovirus B19 DNA replication in human erythroid progenitors through interaction with the MCM complex. PLoS Pathog (2017) 0.76
STAT5 and CD4 (+) T Cell Immunity. F1000Res (2017) 0.75
Molecular Models of STAT5A Tetramers Complexed to DNA Predict Relative Genome-Wide Frequencies of the Spacing between the Two Dimer Binding Motifs of the Tetramer Binding Sites. PLoS One (2016) 0.75
Three Tyrosine Residues in the Erythropoietin Receptor Are Essential for Janus Kinase 2 V617F Mutant-induced Tumorigenesis. J Biol Chem (2016) 0.75
Novel transcripts from a distinct promoter that encode the full-length AKT1 in human breast cancer cells. BMC Cancer (2014) 0.75
DNA methylation and transcription in a distal region upstream from the bovine AlphaS1 casein gene after once or twice daily milking. PLoS One (2014) 0.75
Androgen receptor-dependent and -independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles. Oncotarget (2016) 0.75
Repression of Fyn-related kinase in breast cancer cells is associated with promoter site-specific CpG methylation. Oncotarget (2017) 0.75
Cell cycle progression dictates the requirement for BCL2 in natural killer cell survival. J Exp Med (2017) 0.75
A general method applicable to the search for similarities in the amino acid sequence of two proteins. J Mol Biol (1970) 155.96
STATs and gene regulation. Science (1997) 16.55
Transcriptional activation: a complex puzzle with few easy pieces. Cell (1994) 8.63
Jaks and STATs: biological implications. Annu Rev Immunol (1998) 7.18
STATs: signal transducers and activators of transcription. Cell (1996) 6.10
Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell (1998) 5.92
Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev (1997) 5.57
A sensitive method for the determination of protein-DNA binding specificities. Nucleic Acids Res (1990) 5.42
Three-dimensional structure of the Stat3beta homodimer bound to DNA. Nature (1998) 5.04
Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: a direct role for Stat5 in Bcl-X(L) induction. Cell (1999) 4.69
Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci U S A (1997) 4.11
A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain. Genes Dev (1995) 4.11
Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA. Cell (1998) 3.79
Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity (1999) 3.53
Cooperative DNA binding and sequence-selective recognition conferred by the STAT amino-terminal domain. Science (1996) 3.31
Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two STAT5 homologs. EMBO J (1995) 2.90
Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue. Proc Natl Acad Sci U S A (1995) 2.79
GAS elements: a few nucleotides with a major impact on cytokine-induced gene expression. J Interferon Cytokine Res (1997) 2.40
Interleukin-3 signals through multiple isoforms of Stat5. EMBO J (1995) 2.12
Stat5b is essential for natural killer cell-mediated proliferation and cytolytic activity. J Exp Med (1998) 2.07
An indirect effect of Stat5a in IL-2-induced proliferation: a critical role for Stat5a in IL-2-mediated IL-2 receptor alpha chain induction. Immunity (1997) 2.01
Structure of the amino-terminal protein interaction domain of STAT-4. Science (1998) 2.00
Identification and purification of human Stat proteins activated in response to interleukin-2. Immunity (1995) 1.90
Components of a Stat recognition code: evidence for two layers of molecular selectivity. Immunity (1995) 1.77
Genomic organization, promoter region analysis, and chromosome localization of the mouse bcl-x gene. J Immunol (1997) 1.75
Cloning of human Stat5B. Reconstitution of interleukin-2-induced Stat5A and Stat5B DNA binding activity in COS-7 cells. J Biol Chem (1996) 1.70
The significance of tetramerization in promoter recruitment by Stat5. Mol Cell Biol (1999) 1.62
Interleukin-2 activation of STAT5 requires the convergent action of tyrosine kinases and a serine/threonine kinase pathway distinct from the Raf1/ERK2 MAP kinase pathway. EMBO J (1996) 1.40
Induction of germline transcription in the TCRgamma locus by Stat5: implications for accessibility control by the IL-7 receptor. Immunity (1999) 1.35
A sequence of the CIS gene promoter interacts preferentially with two associated STAT5A dimers: a distinct biochemical difference between STAT5A and STAT5B. Mol Cell Biol (1998) 1.32
Interaction of STAT5 dimers on two low affinity binding sites mediates interleukin 2 (IL-2) stimulation of IL-2 receptor alpha gene transcription. J Biol Chem (1997) 1.18
The human Pim-1 gene is selectively transcribed in different hemato-lymphoid cell lines in spite of a G + C-rich housekeeping promoter. Mol Cell Biol (1990) 1.07
Growth hormone induction of hepatic serine protease inhibitor 2.1 transcription is mediated by a Stat5-related factor binding synergistically to two gamma-activated sites. J Biol Chem (1995) 0.99
A single amino acid in the DNA binding regions of STAT5A and STAT5B confers distinct DNA binding specificities. J Biol Chem (1998) 0.94
Characterization and cloning of STAT5 from IM-9 cells and its activation by growth hormone. Mol Endocrinol (1996) 0.92
A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor. Nature (1982) 9.42
Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity (1996) 8.16
Molecular cloning and expression of cDNAs for the human interleukin-2 receptor. Nature (1984) 7.37
Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell (1993) 6.83
Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor. Science (1993) 5.22
Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription. Proc Natl Acad Sci U S A (1984) 4.90
Regulation of the human interleukin-2 receptor alpha chain promoter: activation of a nonfunctional promoter by the transactivator gene of HTLV-I. Cell (1987) 4.76
An interleukin-4-induced transcription factor: IL-4 Stat. Science (1994) 4.71
Transcriptional activators direct histone acetyltransferase complexes to nucleosomes. Nature (1998) 4.68
Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nat Genet (1998) 4.32
Novel interleukin-2 receptor subunit detected by cross-linking under high-affinity conditions. Science (1986) 4.30
The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity (1995) 3.99
Interleukin 2 (IL-2) augments transcription of the IL-2 receptor gene. Proc Natl Acad Sci U S A (1985) 3.74
Functional analysis of a growth factor-responsive transcription factor complex. Cell (1993) 3.66
Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I. Science (1995) 3.43
Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin. Nat Immunol (2000) 3.42
Expression of interleukin 2 receptors on activated human B cells. J Exp Med (1984) 3.27
Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science (1995) 3.15
Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro. Proc Natl Acad Sci U S A (1991) 3.07
Sequential expression of genes involved in human T lymphocyte growth and differentiation. J Exp Med (1985) 3.04
The G-box: a ubiquitous regulatory DNA element in plants bound by the GBF family of bZIP proteins. Trends Biochem Sci (1995) 2.93
Expanded lysine acetylation specificity of Gcn5 in native complexes. J Biol Chem (1999) 2.91
DNA binding specificity of different STAT proteins. Comparison of in vitro specificity with natural target sites. J Biol Chem (2000) 2.90
Characterization of the human receptor for T-cell growth factor. Proc Natl Acad Sci U S A (1983) 2.76
Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia. Proc Natl Acad Sci U S A (1983) 2.73
Functionally distinct NF-kappa B binding sites in the immunoglobulin kappa and IL-2 receptor alpha chain genes. Science (1989) 2.71
Blockade of the interleukin-2 receptor by anti-Tac antibody: inhibition of human lymphocyte activation. J Immunol (1983) 2.65
The Jak-STAT pathway. Mol Immunol (2000) 2.63
Histone H3 specific acetyltransferases are essential for cell cycle progression. Genes Dev (2001) 2.55
The role of Stat5a and Stat5b in signaling by IL-2 family cytokines. Oncogene (2000) 2.45
Structure of the human interleukin-2 receptor gene. Science (1985) 2.43
The IL-2 receptor beta chain (p70): role in mediating signals for LAK, NK, and proliferative activities. Science (1987) 2.35
The human interleukin-2 receptor. Annu Rev Immunol (1986) 2.29
Regulation of interleukin 2 receptor expression: effects of phorbol diester, phospholipase C, and reexposure to lectin or antigen. J Immunol (1984) 2.20
Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain. Proc Natl Acad Sci U S A (2000) 2.16
No .NO from NO synthase. Proc Natl Acad Sci U S A (1996) 2.14
Regulation of cell-type-specific interleukin-2 receptor alpha-chain gene expression: potential role of physical interactions between Elf-1, HMG-I(Y), and NF-kappa B family proteins. Mol Cell Biol (1995) 2.07
Stat5b is essential for natural killer cell-mediated proliferation and cytolytic activity. J Exp Med (1998) 2.07
Trans-activator gene of HTLV-II induces IL-2 receptor and IL-2 cellular gene expression. Science (1986) 2.03
An indirect effect of Stat5a in IL-2-induced proliferation: a critical role for Stat5a in IL-2-mediated IL-2 receptor alpha chain induction. Immunity (1997) 2.01
The basis for IL-2-induced IL-2 receptor alpha chain gene regulation: importance of two widely separated IL-2 response elements. Immunity (2001) 2.00
Nucleotide sequence and expression of a mouse interleukin 2 receptor cDNA. J Immunol (1985) 2.00
Stable expression of cDNA encoding the human interleukin 2 receptor in eukaryotic cells. J Exp Med (1985) 1.99
Augmented T cell growth factor receptor expression in HTLV-1-infected human leukemic T cells. J Immunol (1984) 1.99
Heterodimerization of the IL-2 receptor beta- and gamma-chain cytoplasmic domains is required for signalling. Nature (1994) 1.93
Identification and purification of human Stat proteins activated in response to interleukin-2. Immunity (1995) 1.90
Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor beta chain but is not essential for the proliferative signal transmission. Proc Natl Acad Sci U S A (1995) 1.89
A frameshift mutation in prominin (mouse)-like 1 causes human retinal degeneration. Hum Mol Genet (2000) 1.87
Purified histone acetyltransferase complexes stimulate HIV-1 transcription from preassembled nucleosomal arrays. Proc Natl Acad Sci U S A (1998) 1.86
Synthesis, biological activity, and molecular modeling of ribose-modified deoxyadenosine bisphosphate analogues as P2Y(1) receptor ligands. J Med Chem (2000) 1.85
Identification and analysis of yeast nucleosomal histone acetyltransferase complexes. Methods (1998) 1.82
Interleukin 2 receptor gene expression in normal human T lymphocytes. Proc Natl Acad Sci U S A (1985) 1.80
The common cytokine receptor gamma chain plays an essential role in regulating lymphoid homeostasis. J Exp Med (1997) 1.79
N-terminal DNA-binding domains contribute to differential DNA-binding specificities of NF-kappa B p50 and p65. Mol Cell Biol (1993) 1.75
High-resolution solution structure of the beta chemokine hMIP-1 beta by multidimensional NMR. Science (1994) 1.74
Nucleosome positioning on the MMTV LTR results from the frequency-biased occupancy of multiple frames. Genes Dev (1995) 1.74
DNA binding activity of the Arabidopsis G-box binding factor GBF1 is stimulated by phosphorylation by casein kinase II from broccoli. Plant Cell (1992) 1.71
Cloning of human Stat5B. Reconstitution of interleukin-2-induced Stat5A and Stat5B DNA binding activity in COS-7 cells. J Biol Chem (1996) 1.70
cDNA cloning and characterization of the human interleukin 13 receptor alpha chain. J Biol Chem (1996) 1.68
Localization of the gene encoding the human interleukin-2 receptor on chromosome 10. Science (1985) 1.66
Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins. Proc Natl Acad Sci U S A (1997) 1.65
Analysis of nucleosome disruption by ATP-driven chromatin remodeling complexes. Methods Mol Biol (1999) 1.65
Requirements for interleukin-4-induced gene expression and functional characterization of Stat6. Mol Cell Biol (1996) 1.64
Functional association of Nmi with Stat5 and Stat1 in IL-2- and IFNgamma-mediated signaling. Cell (1999) 1.64
Psychosocial challenges and protective influences for socio-emotional coping of HIV+ adolescents in South Africa: a qualitative investigation. AIDS Care (2010) 1.62
The significance of tetramerization in promoter recruitment by Stat5. Mol Cell Biol (1999) 1.62
Signaling from the IL-2 receptor to the nucleus. Cytokine Growth Factor Rev (1997) 1.60
Human interleukin 2 receptor beta-chain gene: chromosomal localization and identification of 5' regulatory sequences. Proc Natl Acad Sci U S A (1990) 1.59
Glucocorticoid receptor-dependent disruption of a specific nucleosome on the mouse mammary tumor virus promoter is prevented by sodium butyrate. Proc Natl Acad Sci U S A (1990) 1.58
The role of amino acids in extracellular loops of the human P2Y1 receptor in surface expression and activation processes. J Biol Chem (1999) 1.54
STAT5A-deficient mice demonstrate a defect in granulocyte-macrophage colony-stimulating factor-induced proliferation and gene expression. Blood (1997) 1.53
Receptor for interleukin 13. Interaction with interleukin 4 by a mechanism that does not involve the common gamma chain shared by receptors for interleukins 2, 4, 7, 9, and 15. J Biol Chem (1995) 1.52
Interferons inhibit activation of STAT6 by interleukin 4 in human monocytes by inducing SOCS-1 gene expression. Proc Natl Acad Sci U S A (1999) 1.50
Chronic amiodarone reduces transmural dispersion of repolarization in the canine heart. J Cardiovasc Electrophysiol (1997) 1.49
Different interleukin 2 receptor beta-chain tyrosines couple to at least two signaling pathways and synergistically mediate interleukin 2-induced proliferation. Proc Natl Acad Sci U S A (1996) 1.48
Outbreak of clinically mild botulism type E illness from home-salted fish in patients presenting with predominantly gastrointestinal symptoms. Clin Infect Dis (2007) 1.46
Cloning, characterization, expression, and chromosomal localization of a human ferritin heavy-chain gene. Proc Natl Acad Sci U S A (1986) 1.44
Interleukin-13 upregulates eotaxin expression in airway epithelial cells by a STAT6-dependent mechanism. Am J Respir Cell Mol Biol (2001) 1.42
Essential role of signal transducer and activator of transcription (Stat)5a but not Stat5b for Flt3-dependent signaling. J Exp Med (2000) 1.38
HTLV-1 p12(I) protein enhances STAT5 activation and decreases the interleukin-2 requirement for proliferation of primary human peripheral blood mononuclear cells. Blood (2001) 1.38
Translational mini-review series on Th17 cells: induction of interleukin-17 production by regulatory T cells. Clin Exp Immunol (2009) 1.37
The human interleukin-2 receptor: normal and abnormal expression in T cells and in leukemias induced by the human T-lymphotropic retroviruses. Ann Intern Med (1986) 1.37
Tetralogy of Fallot in adults. A report on 147 patients. Am J Med (1979) 1.34
The human T-cell leukemia/lymphotropic virus type 1 p12I proteins bind the interleukin-2 receptor beta and gammac chains and affects their expression on the cell surface. J Virol (1996) 1.33
Structure-activity relationships and molecular modeling of 3, 5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists. J Med Chem (1998) 1.32
Cigarette advertising in Mumbai, India: targeting different socioeconomic groups, women, and youth. Tob Control (2005) 1.31
Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes. J Med Chem (1998) 1.31
An IL-2 response element in the human IL-2 receptor alpha chain promoter is a composite element that binds Stat5, Elf-1, HMG-I(Y) and a GATA family protein. EMBO J (1996) 1.30
The position and length of the steroid-dependent hypersensitive region in the mouse mammary tumor virus long terminal repeat are invariant despite multiple nucleosome B frames. Mol Cell Biol (1998) 1.30
Kinase CK2 inhibition: an update. Curr Med Chem (2013) 1.29
Elevated serum cyclophilin levels in patients with severe sepsis. J Clin Immunol (1997) 1.28
The human interleukin 2 receptor beta chain (p70). Direct identification, partial purification, and patterns of expression on peripheral blood mononuclear cells. J Exp Med (1988) 1.28
Lipid peroxidative damage on pyrethroid exposure and alterations in antioxidant status in rat erythrocytes: a possible involvement of reactive oxygen species. Toxicol Lett (1999) 1.27
Phorbol diester induces expression of Tac antigen on human acute T lymphocytic leukemic cells. J Immunol (1984) 1.25
Distinct roles for signals relayed through the common cytokine receptor gamma chain and interleukin 7 receptor alpha chain in natural T cell development. J Exp Med (1997) 1.24
Early and late results of pericardiectomy in 118 cases of constrictive pericarditis. Thorax (1988) 1.24
Ornithine cyclodeaminase from Ti plasmid C58: DNA sequence, enzyme properties and regulation of activity by arginine. Eur J Biochem (1988) 1.23